SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates FMTX, MTCR, AAWW

ACCESSWIRE 8-Sep-2022 10:46 AM

NEW YORK, NY / ACCESSWIRE / September 8, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Forma Therapeutics, Holdings Inc. (NASDAQ:FMTX)'s sale to Novo Nordisk for $20.00 per share in cash. If you are a Forma shareholder, click here to learn more about your rights and options.

Metacrine Inc. (NASDAQ:MTCR)'s merger with Equillium, Inc. If you are a Metacrine shareholder, click here to learn more about your rights and options.

Atlas Air Worldwide Holdings, Inc. (NASDAQ:AAWW)'s sale to funds managed by affiliates of Apollo Global Management, Inc. and affiliates of J.F. Lehman & Company and Hill City Capital for $102.50 per share in cash. If you are an Atlas shareholder, click here to learn more about your rights and options.

Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

SOURCE: Halper Sadeh LLP